MicroVision (MVIS) GC gains stock from RSU vesting as issuer sells 77,905 shares for taxes
Rhea-AI Filing Summary
MicroVision, Inc. General Counsel Drew G. Markham reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On June 8, 2026, vested RSUs converted into 118,800 shares of common stock on a unit-for-share basis, and a further 150,000 RSUs were granted.
The filing shows a separate 150,000 RSU award approved under the 2025 Executive Bonus Plan, scheduled to vest in thirds annually through June 6, 2028, contingent on continued employment. On June 10, 2026, 77,905 shares were withheld and sold by the issuer at a weighted average price of $0.3621 per share to satisfy tax obligations.
Following these transactions, Markham directly holds 663,203 shares of MicroVision common stock and 150,000 RSUs. The activity reflects derivative exercises, an RSU grant, and a nondiscretionary, tax-related sell-to-cover event rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insights
Routine RSU vesting, grant, and tax withholding with a net increase in equity.
The transactions center on RSU-based compensation for MicroVision’s General Counsel. On June 8, 2026, 268,800 RSUs vested and converted into common shares, and an additional 150,000 RSUs were granted under the 2025 Executive Bonus Plan, reinforcing equity-linked pay.
A subsequent 77,905-share disposition at a weighted average of $0.3621 per share was executed by the issuer solely to cover withholding taxes, as disclosed in the footnotes. This is a nondiscretionary sell-to-cover mechanism and not an open-market sale reflecting the insider’s trading view.
Post-transaction direct ownership stands at 663,203 shares plus 150,000 RSUs, indicating a larger overall equity stake. The pattern is typical for executive compensation structures that combine performance-based vesting, multi-year vesting schedules through June 6, 2028, and tax withholding in shares instead of cash.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 77,905 | $0.3621 | $28K |
| Grant/Award | Restricted Stock Units | 150,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 150,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 118,800 | $0.00 | -- |
| Exercise | Common Stock | 150,000 | $0.00 | -- |
| Exercise | Common Stock | 118,800 | $0.00 | -- |
Footnotes (1)
- Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis. Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement. The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3509 to $0.3779, inclusive. Each RSU represents a contingent right to receive one share of MicroVision common stock. RSUs vested on June 8, 2026, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2025 Executive Bonus Plan. At vesting, converts into shares of common stock on a unit-for-share basis. On June 6, 2025, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 6, 2028, subject to the Reporting Person's continued employment with the Issuer on each vesting date.